Skip to main content

Table 2 Main results of the pooled ORs in meta-analysis for the association between RNF213 rare variants and MMD or ICASO

From: Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review

Variants

N

Sample size (case/control)

Dominant model

Recessive model

Allelic model

OR (95% CI)

I 2 (%)

p b

p c

OR (95% CI)

I 2 (%)

p b

p c

OR (95% CI)

I 2 (%)

p b

p c

MMD

 (1) p.R4810K (rs112735431)

Total

23

2331/5476

85.91 (56.36–130.95)a

51.6

0.002

< 0.0001

13.19 (6.37–27.31)

0.0

0.886

< 0.0001

46.54 (36.73–58.97)

0.0

0.497

< 0.0001

Subgroup analysis

 Country

  Japan

8

661/1459

184.04 (119.56–283.29)

0.0

0.453

< 0.0001

19.52 (6.30–60.47)

0.0

0.666

< 0.0001

58.64 (40.88–84.12)

0.0

0.621

< 0.0001

   Familial

3

131/1124

1802.44 (472.97–6868,90)

0.0

0.757

< 0.0001

51.70 (11.53–231.80)

0.0

0.676

< 0.0001

77.40 (50.44–117.66)

0.0

0.370

< 0.0001

   Sporadic

8

530/1459

134.35 (86.77–208.02)

17.8

0.289

< 0.0001

9.93 (2.96–33.30)

0.0

0.884

< 0.0001

52.08 (35.41–76.60)

0.0

0.504

< 0.0001

  Korea

7

922/2278

109.77 (76.30–157.93)

0.0

0.889

< 0.0001

17.38 (3.08–98.07)

38.6

0.196

0.001

42.81 (30.25–60.57)

0.0

0.804

< 0.0001

   Familial

1

46/294

512.42 (130.85–2006.64)

–

–

< 0.0001

33.09 (1.56–700.58)

–

–

0.025

69.41 (30.92–155.83)

–

–

< 0.0001

   Sporadic

7

876/2278

99.82 (69.22–143.93)

0.0

0.858

< 0.0001

17.62 (3.14–99.02)

42.4

0.176

0.001

49.52 (35.11–69.85)

0.0

0.933

< 0.0001

  China

8

748/1739

31.53 (16.18–61.46)

24.2

0.236

< 0.0001

5.48 (1.64–18.35)

0.0

0.999

0.006

31.51 (16.02–62.00)

22.0

0.3

< 0.0001

   Familial

2

40/807

1109.02 (99.39–12,375.41)

0.0

0.943

< 0.0001

338.33 (12.08–9475.51)

–

–

0.001

575.09 (60.07–5505.59)

0.0

0.9891

< 0.0001

   Sporadic

8

743/1739

30.52 (15.63–59.59)

21.9

0.256

< 0.0001

5.12 (1.40–18.77)

0.0

0.998

0.014

29.77 (15.19–58.35)

5.3

0.390

< 0.0001

Total

   Familial

6

217/2225

1116.56 (462.75–2684.12)

0.0

0.849

< 0.0001

51.86 (14.18–189.64)

0.0

0.720

< 0.0001

85.35 (59.09–123.27)

22.7

0.156

< 0.0001

   Sporadic

23

2139/5476

75.03 (50.67–111.09)a

43.6

0.014

< 0.0001

9.41 (4.36–20.32)

0.0

0.957

< 0.0001

46.34 (36.32–59.13)

0.0

0.633

< 0.0001

(2) p.R2092C (rs139265462)

 Total

2

80/80

3.27 (0.32–33.80)

0.0

0.949

0.321

–

–

–

–

3.13 (0.31–31.28)

0.0

0.974

0.331

(3) p.D4013N (rs397514563)

 Total

3

285/432

6.47 (0.96–43.55)

0.0

0.443

0.055

–

–

–

–

6.18 (0.92–41.33)

0.0

0.433

0.06

(4) p.R4062Q

 Total

3

400/559

4.64 (0.72–29.96)

0.0

0.798

0.107

–

–

–

–

4.62 (0.72–29.76)

0.0

0.798

0.107

(5) p.A4399T (rs148731719)

 Total

5

585/924

1.15(0.41–3.25)a

70.8

0.008

0.79

4.80 (0.49–47.02)

0.0

0.611

0.178

1.19 (0.45–3.19)a

69.2

0.011

0.727

Subgroup analysis

 Japan

2

267/241

0.85(0.43–1.68)

0.0

0.374

0.636

2.78 (0.11–68.63)

–

–

0.532

0.90 (0.46–1.76)

0.0

0.426

0.767

 China

3

318/683

1.13(0.06–21.30)a

80.1

0.007

0.933

8.98 (0.36–221.54)

–

–

0.179

1.04 (0.07–15.72)a

79.6

0.007

0.975

(6) p.E4950D (rs371441113)

 Total

3

477/957

9.06 (1.49–55.27)

0.0

0.915

0.017

–

–

–

–

9.00 (1.48–54.78)

0.0

0.917

0.017

(7) p.A5021V (rs138130613)

 Total

4

324/827

5.01(1.57–15.98)

0.0

0.738

0.006

–

–

–

–

4.91 (1.55–15.53)

0.0

0.733

0.007

ICASO

 p.R4810K (rs112735431)

  Total

11

1778/3140

13.89 (8.01–24.09)

37.0

0.140

< 0.0001

2.70 (0.28–26.38)

0.0

0.764

0.394

13.01 (7.55–22.42)

18.3

0.269

< 0.0001

Subgroup analysis

 Japan

3

229/235

10.71 (3.97–28.91)

0.0

0.537

< 0.0001

1.89 (0.07–48.17)

–

–

0.7

10.00 (3.74–26.77)

0.0

0.570

< 0.0001

 Korea

4

517/1750

28.52 (11.04–73.67)

0.0

0.779

< 0.0001

–

–

–

–

24.16 (9.71–60.13)

0.0

0.845

< 0.0001

 China

4

1032/1155

5.59 (2.12–14.75)

11.6

0.335

0.001

3.80 (0.15–94.95)

–

–

0.416

5.76 (7.55–22.42)

13.0

0.328

< 0.0001

  1. N number of studies, − not available
  2. aORs were calculated under random-effects model
  3. b p value for Q test
  4. c p value for Z test, I 2, Higgins I 2 statistic